Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular ...
11h
Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...
ASX small-cap shares are slightly outperforming the broader market in 2025. The post Experts reveal 4 ASX small-cap shares to ...
Acceptance follows resolution of third-party fill/finish manufacturing issues FDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc.
CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...
The following highlights showcase the most pivotal, innovative research published across multiple therapeutic areas in ...
More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...
A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...
Nathan Congdon, MD, highlights a recent study showing how virtual mentor-mentee relationships through Orbis' free ...
Vertex Pharmaceuticals is working toward making its recently approved non-opioid pain medicine Journavx not only broadly ...
Yahoo News provides the latest updates on the spread of bird flu in the U.S. and its effect on rising egg prices and ...
GOMEKLI™ is an oral, small molecule MEK inhibitor approved in the United States for the treatment of adult and pediatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback